Similar to the effects in breast cancer cell lines, Nek2 siRNA impaired the in vitro proliferation of the DLD-1 and Colo320 carcinoma cell lines, as well as xenografts generated by injection of DLD-1 cells [76]. This evidence concerns the gene NEK2 and breast carcinoma.